TLDR:
- Tierra Biosciences raised $11.4M in Series A funding led by Material Impact.
- The funding will be used to expand operations and R&D.
Tierra Biosciences, a company based in San Leandro, CA, has secured $11.4M in Series A funding. The round was led by Material Impact, with participation from other investors such as Prosus Ventures, In-Q-Tel, Hillspire, Freeflow Ventures, Creative Ventures, and Social Capital. The company, led by CEO Michael Nemzek, specializes in predictive AI-guided cell-free technology platform. Their mission is to democratize access to proteins for sectors like human health, environmental sustainability, and global food security. The funding will be used to expand operations and research and development efforts.
